Simcere was founded on March 28, 1995 with an enterprise mission to "discover and develop high-quality medicines for patients." Since its inception, we have grown from a registered capital of 2.78 mil...
Business Type: | Manufacturer/Factory,Trading Company | |
Main Products: | Anti-Tumor Drug (Recombinant Human Endostatin Injection, Pemetrexed disodium for Injection, Palonosetron Hydrochloride for Injection, Nedaplatin for Injection), Central Nervous Drug (Edaravone injection), Anti-Infection Drug (Biapenem for Injection), Card, | |
Established Year: | 1995 | |
Registered Capital: | 1 Million RMB | |
OEM/ODM Availability: | Yes |
Simcere was founded on March 28, 1995 with an enterprise mission to "discover and develop high-quality medicines for patients." Since its inception, we have grown from a registered capital of 2.78 million to total assets of over 3 billion yuan, from a few dozen people to an R&D-driven pharmaceutical enterprise with more than 3,000 talents, and from an annual tax of less than a million to about 500 million yuan. We have ranked among "the top 100 Chinese Pharmaceutical Companies" for consecutive years, and our growth goes beyond the numbers.To fulfill our dream, we have progressed through a string of strategic options, including but not limited to the development of first generic products, merger and acquisition, the build-up of research institute, an alliance with multinational corporations, and innovative research mechanisms. At present, these efforts are bearing fruits:In 2009, our montmorillonite powder product successfully passed EU GMP certification and started exporting to ...